Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Agents, Embolic, For Treatment Of Uterine Fibroids

FDA product code NAJ · 7 cleared devices

Class 2 Cardiovascular
Regulation
21 CFR 870.3300
Review panel
OB
Implant
Yes
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
2002-11-22 – 2023-12-21
↑